Ndonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,436 | -10,810 | -5,316 | -6,766 | -960 |
| Depreciation Amortization | 4,211 | 2,181 | 1,071 | 15 | 16 |
| Accounts receivable | -3 | N/A | N/A | N/A | N/A |
| Other Working Capital | 879 | 408 | 617 | 903 | 1,392 |
| Other Operating Activity | -1,530 | 5,232 | 1,165 | 4,829 | -1,357 |
| Operating Cash Flow | $-2,879 | $-2,990 | $-2,462 | $-1,019 | $-909 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | N/A | -4 | N/A |
| Purchase Sale Intangibles | N/A | -3,000 | N/A | N/A | N/A |
| Other Investing Activity | 0 | -3,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-9 | $-3,000 | $N/A | $-4 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 65 | 126 | 13 | 101 | N/A |
| Debt Issued | 2,836 | 4,047 | 1,492 | 1,086 | 936 |
| Debt Repayment | -560 | -132 | -179 | -150 | N/A |
| Common Stock Issued | 85 | 1,295 | 1,236 | 139 | N/A |
| Other Financing Activity | 751 | 689 | -85 | -113 | -29 |
| Financing Cash Flow | $3,177 | $6,024 | $2,476 | $1,064 | $907 |
| Beginning Cash Position | 90 | 56 | 42 | 1 | 3 |
| End Cash Position | 379 | 90 | 56 | 42 | 1 |
| Net Cash Flow | $289 | $35 | $14 | $41 | $-2 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,879 | -2,990 | -2,462 | -1,019 | -909 |
| Capital Expenditure | -9 | N/A | N/A | -4 | N/A |
| Free Cash Flow | -2,888 | -2,990 | -2,462 | -1,023 | -909 |